期刊文献+

脓毒症患者降钙素原水平持续性监测的意义 被引量:7

The Significance of Monitoring of Dynamic Variation of Procalcitonin Level in Sepsis Patients
下载PDF
导出
摘要 目的探讨脓毒症患者血清降钙素原(PCT)水平动态变化的规律及其意义。方法采用前瞻性队列研究入选2012年11月至2013年10月于兰州军区兰州总医院重症监护治疗病房、急诊科病房、呼吸内科重症监护治疗病房住院的所有脓毒症患者,依据脓毒症严重程度分为脓毒症组、严重脓毒症组和脓毒性休克组,于入选后第1、3、5、7日4个时间点分别检测每例患者血清PCT水平,同时对其进行急性生理与慢性健康状态评分Ⅱ评分。结果总共纳入235例合格研究对象,28 d内的病死率为21.3%(50/235),脓毒症组和脓毒性休克组第1、3、5、7日PCT水平呈下降趋势,严重脓毒症组PCT水平呈先升高后下降的趋势(P<0.01)。死亡组和存活组PCT水平比较差异有统计学意义,死亡组PCT水平高于存活组(P<0.01);两组入院不同时点间PCT水平比较差异有统计学意义,均呈下降趋势(P<0.01)。结论血清PCT水平下降程度小者病死率高,血清PCT作为脓毒症一项有用的检测指标可指导其病情和预后。 Objective To investigate the rule and significance of dynamic variation of serum procalcitonin( PCT) level in sepsis patients. Methods This was a prospective cohort study. In this study,we selected all eligible patients from ICU,the emergency room and ICU of respiration medicine in Lanzhou General Hospital from Nov. 2012 to Oct. 2013. Serum PCT levels were analyzed from blood samples of those at baseline on admission and at 1st,3rd,5th,7th afterwards,and the acute physiology and chronic health evaluation Ⅱ( APACHEⅡ) scores were given. Results Altogether 235 eligible patients were selected. The 28-day mortality was 21. 3%( 50 /235),the PCT level of the sepsis group and sepsis shock group showed down trend on the 1st,3rd,5th,and 7th day,while in the severe sepsis group it showed first up then down trend( P 0. 01). The PCT level of the death group was statistically significantly higher than the survival group( P 0. 01); PCT levels of the two groups at different times points were statistically significantly different,while they were both in a down trend( P 0. 01). Conclusion The mortality of the group with smaller PCT decrease is higher. Serum PCT can be used as a useful biomarker to indicate the condition of sepsis and the prognosis.
出处 《医学综述》 2015年第2期308-309,314,共3页 Medical Recapitulate
基金 全军十二五后勤科研面上项目(CWS11J230)
关键词 脓毒症 降钙素原 动态变化 重症监护治疗病房 休克 Sepsis Procalcitonin Dynamic variation Intensive care unit Shock
  • 相关文献

参考文献13

  • 1Vincent JL,Abraham E.The Last 100 years of sepsis[J].Am JRespir Crit Care Med,2006,173(3):256-263.
  • 2Nakamura A,Wada H,Ikejiri M,et al.Efficacy of procalcitonin inthe early diagnosis of bacterial infections in a critical care unit[J].Shock,2009,31(6):586-591.
  • 3Simon L,Gauvin F,Amre DK,et al.Serum procalcitonin andC-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J].Clin Infect Dis,2004,39(2):206-217.
  • 4Bloos F,Reinhart K.Rapid diagnosis of sepsis[J].Virulence,2013,5(1):1-7.
  • 5Müller B,White JC,Nylén ES,et al.Ubiquitous expression of thecalcitonin-igene in multiple tissues in response to sepsis[J].JClin Endocrinol Metab,2001,86(1):396-404.
  • 6Koskenvuo MM,Irjala K,Kinnala A,et al.Value of monitoring serum procalcitonin in neonates at risk of infection[J].Eur J ClinMicrobiol Infect Dis,2003,22(6):377-378.
  • 7Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS inter-national sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 8Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:a severityof disease classification system[J].Crit Care Med,1985,13(10):818-829.
  • 9Müller B,Harbarth S,Stolz D,et al.Diagnostic and prognosticaccuracy of clinical and laboratory parameters in communityacquired pneumonia[J].BMC Infect Dis,2007,7:10.
  • 10Lee H.Procalcitonin as a biomarker of infectious diseases[J].Korean J Intern Med,2013,28(3):285-291.

同被引文献75

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2Anand D,Das S,Bhargava S,et al. Procaleitonin as a rapid diagnostic biomarker to differentiate between culture-neg- ative bacterial sepsis and systemic inflammatory response syndrome : A prospective, observational, cohort study[-J~. J Crit Care,2015,30(1) :e7-12.
  • 3Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign:international guidelines for management of se- vere sepsis and septic shock, 2012 [-J~. Intensive Care Med,2013,39(2) : 165-228.
  • 4Kremmer E, Meyer K, Grasser FA, et al. A new strategy for the development of monoclonal antibodies for the de- termination of human procalcitonin in serum samples[-J]. Anal Bioanal Chem,2012,402(2) :989-995.
  • 5Claessens YE, Schmidt J, Batard E, et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natri uretie peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis(BIS) multicentre study[J~. Clin Micrbiol Infect, 2010,16(6) : 753-760.
  • 6De Azevdo JR,Torres OJ ,Beraldi RA,et al. Prognostic e- valuation of severe sepsis and septic shock: Procalcitonin clearance vs A Sequential Organ Failure AssessnaentEJ~. J Crit Care,2015,30(1) :219. e9-12.
  • 7邢豫宾,戴路明,赵芝焕,李志伟,李超.血清降钙素原和常用炎症指标结合SOFA评分对脓毒症早期诊断和预后价值的评价[J].中国危重病急救医学,2008,20(1):23-28. 被引量:122
  • 8Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Crit Care Med,2003,31 (4) : 1250-1256.
  • 9Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis [ J ]. N Engl J Med,2003,348 (2) : 138-150.
  • 10Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS [ J ]. Crit Care Med, 1996,24 (7) : 1125-1128.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部